| A community effort to assess and improve drug sensitivity prediction algorithms JC Costello, LM Heiser, E Georgii, M Gönen, MP Menden, NJ Wang, ... Nature biotechnology 32 (12), 1202-1212, 2014 | 774 | 2014 |
| Heritability and genomics of gene expression in peripheral blood FA Wright, PF Sullivan, AI Brooks, F Zou, W Sun, K Xia, V Madar, ... Nature genetics 46 (5), 430-437, 2014 | 416 | 2014 |
| Structure-based classification predicts drug response in EGFR-mutant NSCLC JP Robichaux, X Le, RSK Vijayan, JK Hicks, S Heeke, YY Elamin, HY Lin, ... Nature 597 (7878), 732-737, 2021 | 272 | 2021 |
| Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts XY Woo, J Giordano, A Srivastava, ZM Zhao, MW Lloyd, R de Bruijn, ... Nature genetics 53 (1), 86-99, 2021 | 153 | 2021 |
| DINGO: differential network analysis in genomics MJ Ha, V Baladandayuthapani, KA Do Bioinformatics 31 (21), 3413-3420, 2015 | 141 | 2015 |
| An improved patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses IM Meraz, M Majidi, F Meng, RP Shao, MJ Ha, S Neri, B Fang, SH Lin, ... Cancer immunology research 7 (8), 1267-1279, 2019 | 123 | 2019 |
| Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer NM Kettner, S Vijayaraghavan, MG Durak, T Bui, M Kohansal, MJ Ha, ... Clinical Cancer Research 25 (13), 3996-4013, 2019 | 101 | 2019 |
| Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment H Sun, S Cao, RJ Mashl, CK Mo, S Zaccaria, MC Wendl, SR Davies, ... Nature communications 12 (1), 5086, 2021 | 75 | 2021 |
| Cytoplasmic cyclin E predicts recurrence in patients with breast cancer KK Hunt, C Karakas, MJ Ha, A Biernacka, M Yi, AA Sahin, O Adjapong, ... Clinical Cancer Research 23 (12), 2991-3002, 2017 | 56 | 2017 |
| Systematic establishment of robustness and standards in patient-derived xenograft experiments and analysis YA Evrard, A Srivastava, J Randjelovic, JH Doroshow, DA Dean, ... Cancer research 80 (11), 2286-2297, 2020 | 50 | 2020 |
| In Vitro Screening for Population Variability in Chemical Toxicity SH O'Shea, J Schwarz, O Kosyk, PK Ross, MJ Ha, FA Wright, I Rusyn Toxicological Sciences 119 (2), 398-407, 2011 | 39 | 2011 |
| PenPC: A two‐step approach to estimate the skeletons of high‐dimensional directed acyclic graphs MJ Ha, W Sun, J Xie Biometrics 72 (1), 146-155, 2016 | 28 | 2016 |
| Personalized integrated network modeling of the cancer proteome atlas MJ Ha, S Banerjee, R Akbani, H Liang, GB Mills, KA Do, ... Scientific reports 8 (1), 14924, 2018 | 26 | 2018 |
| Partial correlation matrix estimation using ridge penalty followed by thresholding and re‐estimation MJ Ha, W Sun Biometrics 70 (3), 762-770, 2014 | 26 | 2014 |
| Targeting replicative stress and DNA repair by combining PARP and Wee1 kinase inhibitors is synergistic in triple negative breast cancers with cyclin E or BRCA1 alteration X Chen, D Yang, JPW Carey, C Karakas, C Albarracin, AA Sahin, BK Arun, ... Cancers 13 (7), 1656, 2021 | 21 | 2021 |
| Bayesian hierarchical varying-sparsity regression models with application to cancer proteogenomics Y Ni, FC Stingo, MJ Ha, R Akbani, V Baladandayuthapani Journal of the American Statistical Association 114 (525), 48-60, 2019 | 21 | 2019 |
| Bayesian structure learning in multilayered genomic networks MJ Ha, FC Stingo, V Baladandayuthapani Journal of the American Statistical Association 116 (534), 605-618, 2021 | 20 | 2021 |
| Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes YS Chun, T Mizuno, JM Cloyd, MJ Ha, K Omichi, CWD Tzeng, TA Aloia, ... European Journal of Surgical Oncology 46 (9), 1588-1595, 2020 | 20 | 2020 |
| An improved patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses. Cancer Immunol. Res. 2019; 7: 1267–1279. doi: 10.1158/2326-6066 IM Meraz, M Majidi, F Meng, R Shao, MJ Ha, S Neri, B Fang, SH Lin, ... CIR-18-0874.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 20 | |
| Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2− metastatic breast cancer patients compared to endocrine therapy alone in the second‐line … MJ Ha, A Singareeka Raghavendra, NM Kettner, W Qiao, S Damodaran, ... International journal of cancer 150 (12), 2025-2037, 2022 | 17 | 2022 |
Kim-Anh DoMD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
